Huff, Christy

Experiences with benzodiazepine use, tapering, and discontinuation: an Internet survey

Reid Finlayson, A. J., Macoubrie, J., Huff, C., Foster, D. E., & Martin, P. R. (2022) · Therapeutic Advances in Psychopharmacology

Pharmaceutical Practices and Patient OutcomesSubstance Abuse Treatment and Outcomes

Cited by 40

Long-term consequences of benzodiazepine-induced neurological dysfunction: A survey

Ritvo, A. D., Foster, D. E., Huff, C., Finlayson, A. J. R., Silvernail, B., & Martin, P. R. (2023) · PLOS ONE

Substance Abuse Treatment and OutcomesPharmaceutical Practices and Patient Outcomes

Cited by 38

Enduring neurological sequelae of benzodiazepine use: an Internet survey

Huff, C., Finlayson, A. J. R., Foster, D. E., & Martin, P. R. (2023) · Therapeutic Advances in Psychopharmacology

Substance Abuse Treatment and OutcomesPharmaceutical Practices and Patient Outcomes

Cited by 18

Identifying priorities for future research on reducing and stopping psychiatric medication: results of a James Lind Alliance priority-setting partnership

Boland, M., Higgins, A., Beecher, C., Bracken, P., Burn, W., Cody, A., Framer, A., Gronlund, T., Horowitz, M., Huff, C., et al. (2024) · BMJ Open

Mental Health and Patient InvolvementMental Health Treatment and Access

Cited by 14

‘We need more support and doctors that understand the process of tapering …’: A content analysis of free‐text responses to a questionnaire on discontinuing long‐term benzodiazepine receptor agonist use

Lynch, T., Ryan, C., Huff, C., Foster, D. E., & Cadogan, C. (2024) · Health Expectations

Pharmaceutical Practices and Patient OutcomesSubstance Abuse Treatment and Outcomes

Cited by 11